204 related articles for article (PubMed ID: 8037209)
41. Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population.
Bargal R; Avidan N; Olender T; Ben Asher E; Zeigler M; Raas-Rothschild A; Frumkin A; Ben-Yoseph O; Friedlender Y; Lancet D; Bach G
Hum Mutat; 2001 May; 17(5):397-402. PubMed ID: 11317355
[TBL] [Abstract][Full Text] [Related]
42. Niemann-Pick disease: mutation update, genotype/phenotype correlations, and prospects for genetic testing.
Schuchman EH; Miranda SR
Genet Test; 1997; 1(1):13-9. PubMed ID: 10464620
[TBL] [Abstract][Full Text] [Related]
43. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin.
Shahrabani-Gargir L; Shomrat R; Yaron Y; Orr-Urtreger A; Groden J; Legum C
Genet Test; 1998; 2(4):293-6. PubMed ID: 10464606
[TBL] [Abstract][Full Text] [Related]
44. Mutations of the hexosaminidase A gene in Ashkenazi and non-Ashkenazi Jews.
Peleg L; Karpati M; Gazit E; Raas-Rothschild A; Goldman B
Biochem Med Metab Biol; 1994 Jun; 52(1):22-6. PubMed ID: 7917464
[TBL] [Abstract][Full Text] [Related]
45. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
[TBL] [Abstract][Full Text] [Related]
46. [Phosphofructokinase (PFK)].
Nakajima H
Nihon Rinsho; 1995 May; 53(5):1241-6. PubMed ID: 7602786
[TBL] [Abstract][Full Text] [Related]
47. A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: identification and frequency estimation.
Cao Z; Natowicz MR; Kaback MM; Lim-Steele JS; Prence EM; Brown D; Chabot T; Triggs-Raine BL
Am J Hum Genet; 1993 Dec; 53(6):1198-205. PubMed ID: 7902672
[TBL] [Abstract][Full Text] [Related]
48. Ashkenazi Jewish genomic variants: integrating data from the Israeli National Genetic Database and gnomAD.
Zlotogora J; Patrinos GP; Meiner V
Genet Med; 2018 Aug; 20(8):867-871. PubMed ID: 29144512
[TBL] [Abstract][Full Text] [Related]
49. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
Laitman Y; Kaufman B; Lahad EL; Papa MZ; Friedman E
Isr Med Assoc J; 2007 Nov; 9(11):791-6. PubMed ID: 18085035
[TBL] [Abstract][Full Text] [Related]
50. Carrier frequency of the IVS4 + 4 A-->T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population.
Verlander PC; Kaporis A; Liu Q; Zhang Q; Seligsohn U; Auerbach AD
Blood; 1995 Dec; 86(11):4034-8. PubMed ID: 7492758
[TBL] [Abstract][Full Text] [Related]
51. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
Berman DB; Costalas J; Schultz DC; Grana G; Daly M; Godwin AK
Cancer Res; 1996 Aug; 56(15):3409-14. PubMed ID: 8758903
[TBL] [Abstract][Full Text] [Related]
52. Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin.
Leitersdorf E; Reshef A; Meiner V; Levitzki R; Schwartz SP; Dann EJ; Berkman N; Cali JJ; Klapholz L; Berginer VM
J Clin Invest; 1993 Jun; 91(6):2488-96. PubMed ID: 8514861
[TBL] [Abstract][Full Text] [Related]
53. Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene.
Anderson SL; Ekstein J; Donnelly MC; Keefe EM; Toto NR; LeVoci LA; Rubin BY
Hum Genet; 2004 Aug; 115(3):185-90. PubMed ID: 15221447
[TBL] [Abstract][Full Text] [Related]
54. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
Walsh T; Mandell JB; Norquist BM; Casadei S; Gulsuner S; Lee MK; King MC
JAMA Oncol; 2017 Dec; 3(12):1647-1653. PubMed ID: 28727877
[TBL] [Abstract][Full Text] [Related]
55. Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations.
Asakai R; Chung DW; Ratnoff OD; Davie EW
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7667-71. PubMed ID: 2813350
[TBL] [Abstract][Full Text] [Related]
56. A deleterious mutation in the LOXHD1 gene causes autosomal recessive hearing loss in Ashkenazi Jews.
Edvardson S; Jalas C; Shaag A; Zenvirt S; Landau C; Lerer I; Elpeleg O
Am J Med Genet A; 2011 May; 155A(5):1170-2. PubMed ID: 21465660
[TBL] [Abstract][Full Text] [Related]
57. Phosphofructokinase deficiency: recent advances in molecular biology.
Nakajima H; Hamaguchi T; Yamasaki T; Tarui S
Muscle Nerve Suppl; 1995; 3():S28-34. PubMed ID: 7603524
[TBL] [Abstract][Full Text] [Related]
58. The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.
Shtoyerman-Chen R; Friedman E; Figer A; Carmel M; Patael Y; Rath P; Fidder HH; Bar-Meir S; Theodor L
Genet Test; 2001; 5(2):141-6. PubMed ID: 11551102
[TBL] [Abstract][Full Text] [Related]
59. Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews.
Nestorowicz A; Wilson BA; Schoor KP; Inoue H; Glaser B; Landau H; Stanley CA; Thornton PS; Clement JP; Bryan J; Aguilar-Bryan L; Permutt MA
Hum Mol Genet; 1996 Nov; 5(11):1813-22. PubMed ID: 8923011
[TBL] [Abstract][Full Text] [Related]
60. Diverse growth hormone receptor gene mutations in Laron syndrome.
Berg MA; Argente J; Chernausek S; Gracia R; Guevara-Aguirre J; Hopp M; Pérez-Jurado L; Rosenbloom A; Toledo SP; Francke U
Am J Hum Genet; 1993 May; 52(5):998-1005. PubMed ID: 8488849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
